Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-25

FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Pataday Once Daily Relief (olopatadine hydrochloride) by Alcon Laboratories, expanding the labeling for this ocular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)

Snippet

SUPPL AP for PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)